Vicore Pharma Holding AB (publ)

kr 10.22As of Sun 8 Nov 2026, 12:00 UTC
STO:VICOHealthcare
Country Sweden
PE (Fwd) •••
TSR 10Y CAGR 2.34%
Div yield —
ROE (68.83%)
Biotechnology
Beta (5Y) 0.10
PE TTM —
TSR TTM (9.88%)
Mkt cap kr 2.877B
ROIC (45.48%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
kr 11
7.81%
(96.60%)
Hold 8|6|1|12|4
4Q25
1Q26
2Q26
3Q26
Earnings per sharekr
0.15
0.16
0.16
0.18
18.67%
25.73%
16.26%
19.18%
Revenuekr M
175.6
179.8
181.5
176.2
10.25%
12.95%
10.98%
2.35%
Peers (US$290.9M)
Cap (US$)
PE
156.3M
8.576x
Capital
TTM
5Y
10Y
Leveragex
1.161
—
—
EBIT/Intx
0.452
2.925
2.671
Own earn%
0.52
130.79
113.37
Sh yield%
19.33
9.24
10.74
Owners
Insiders/Inst%
6.66
28.20
Short interest%
5.65
SBC / revenue%
1.26
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
23
Op margin range%
3–10
$1 testx
—
Incr. ROIC%
13